epcoritamab
abbvie,genmab
['lymsm', 'dlbcl', 'epcoritamab']
#eha2022 sq #epcoritamab with gemox induced high response rates in pts with r/r #dlbcl ineligible for autologous stem cell transplantation #lymsm #bmtsm 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @SIOGorg. Councilor @EHA_Hematology Executive Board. Chairman SWG “Aging and Hematology”